Orange Book product · Generic (ANDA)
PANTOPRAZOLE SODIUM
PANTOPRAZOLE SODIUM
At a glance
May 16, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 16, 2025
1 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
PANTOPRAZOLE SODIUM
Strength
EQ 40MG BASE/VIAL
Dosage form
INJECTABLE
Route
INTRAVENOUS
TE code
AP
Application
ANDA 215074
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PANTOPRAZOLE SODIUM
- 2024PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 217512 · BAXTER HLTHCARE CORP
- 2017PANTOPRAZOLE SODIUMBrand (NDA)
NDA 209463 · HIKMA
- 2007PROTONIXBrand (NDA)
NDA 022020 · WYETH PHARMS
- 2001PROTONIXBrand (NDA)
NDA 020987 · WYETH PHARMS
- 2001PROTONIX IVBrand (NDA)
NDA 020988 · WYETH PHARMS
- 2026PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 219973 · SHUANGCHENG
- 2025PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 217923 · AUROBINDO PHARMA LTD
- 2025PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 217458 · CIPLA
- 2025PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 219230 · ALEMBIC
- 2025PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 219087 · GRAVITI PHARMS
- 2024PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 216021 · FRESENIUS KABI USA
- 2024PANTOPRAZOLE SODIUMGeneric (ANDA)
ANDA 215880 · MANKIND PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
